228 results
6-K
EX-3.1
GMVDF
G Medical Innovations Holdings Ltd.
18 Dec 23
Report of Foreign Private Issuer
4:39pm
of the issue or re-designation of any Shares and includes credited as fully paid;
where an Ordinary Resolution is expressed to be required for any purpose … , a Special Resolution is also effective for that purpose;
sections 8 and 19(3) of the Electronic Transactions Act are hereby excluded; and
a reference
6-K
EX-99.2
GMVDF
G Medical Innovations Holdings Ltd.
29 Nov 23
Notice of Extraordinary General Meeting
12:00am
as fully paid;
(o) where an Ordinary Resolution is expressed to be required for any purpose, a Special Resolution is also effective for that purpose … For the purpose of the foregoing, the creation of any pledge, charge, encumbrance or other third party right of whatever description on any of Preferred Shares
6-K
EX-99.1
GMVDF
G Medical Innovations Holdings Ltd.
10 Oct 23
Securities Purchase Agreement
4:01pm
in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation
6-K
EX-99.2
GMVDF
G Medical Innovations Holdings Ltd.
25 Aug 23
Notice of Annual General Meeting
4:20pm
each, which would rank equally with all existing Shares (the “Share Capital Increase”).
The purpose of the Share Capital Increase is to ensure … or entity that is not an Affiliate of such holder.
For the purpose of the foregoing, the creation of any pledge, charge, encumbrance or other third
F-1
GMVDF
G Medical Innovations Holdings Ltd.
27 Jul 23
Registration statement (foreign)
4:47pm
or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. You are required … for this purpose represents the difference between the price per Ordinary Share paid by these purchasers and as adjusted net tangible book value per
S-8
EX-5.1
5973l eql
5 Jul 23
Registration of securities for employees
7:37am
S-8
0lnl0vg0a
5 Jul 23
Registration of securities for employees
7:37am
S-8
EX-99.1
x53kzs7sgtfp b2i
5 Jul 23
Registration of securities for employees
7:37am
424B4
g6dz17f5wi0z
4 Apr 23
Prospectus supplement with pricing info
12:13pm
6-K
EX-99.1
lcp7rl1 n38ui
16 Dec 22
Notice of Extraordinary General Meeting
5:15pm
6-K/A
EX-5.1
2r8op18pmep
29 Nov 22
Current report (foreign) (amended)
4:30pm
6-K
EX-99.1
d8ebj96e
18 Nov 22
Report of Foreign Private Issuer
12:34pm
6-K
EX-99.1
xrda8 0791ihsvuty7
9 Nov 22
Notice of Extraordinary General Meeting
2:05pm
6-K
EX-99.1
b6htq1la
31 Oct 22
Notice of Extraordinary General Meeting
6:16pm
6-K
EX-99.2
8t37anius25t1re jadr
27 Oct 22
Securities Purchase Agreement
4:44pm
6-K
EX-99.1
f1ittbjnorg7t3xl88m
27 Oct 22
Securities Purchase Agreement
4:44pm
6-K
EX-99.3
kc9 2na3u3va2v7g
27 Oct 22
Securities Purchase Agreement
4:44pm
424B5
1mtqif0t4tttt9l0
19 Sep 22
Prospectus supplement for primary offering
6:49am